breast-cancer

Documents about breast-cancer

• Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer.#156822NCBI PubMed Central
• Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.#232228NCBI PubMed Central
• Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3.#236175NCBI PubMed Central
• Translating the EORTC CAT core and the QLQ-C30 to the EQ-5D-5L in patients with metastatic breast cancer: A comparison of direct and indirect mapping algorithms#240330Ora Oxford University Research
• Human factors validation study of an artificial neural network‑based preoperative decision‑support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN99301435).#244238NCBI PubMed Central
• Avaliação da atividade inibitória da proteína tipo Lisil oxidase 2 (LOXL2) de pimaranos e seus derivados glicosídicos#263362RCAAP
• Supplementary Material for: Cytokine release syndrome induced by neoadjuvant pembrolizumab in early triple-negative breast cancer: a case report with implications for early diagnosis and management#279901Figshare
• Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.#221242NCBI PubMed Central
• PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial#240329Ora Oxford University Research
• NOXA/MCL-1 axis determines cell-death decision between apoptosis and a GSDME-dependent cell death associated with production of inflammatory cytokines upon treatment of breast cancer cells with antimitotics#284387HAL (France)
• Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial#326123HAL (France)
• Supporting data for "The development and pilot testing of a nurse-led and mobile instant messaging-delivered oncofertility psychoeducational intervention among young women with breast cancer"#333572Figshare
• Effects of digital exercise therapy and cognitive behavioral therapy on body image and social distance of postoperative patients with breast cancer: study protocol for a randomized controlled trial.#340603NCBI PubMed Central
• A Peer-Led, Nurse-Involved Blended Online and Offline Peer Support Program (PNO2PSP) for Psychosocial Adjustment in Young- to Middle-Aged Patients With Breast Cancer: Cluster Randomized Clinical Trial.#30847NCBI PubMed Central
• Synthesis and biological evaluation of benzimidazolyl phenylpropenones as selective anticancer agents in prostate colon and breast cancer models#156045HAL (France)
• Node properties of biomarkers within the protein–protein interaction network derived from breast cancer-associated genes#158299PLOS
• Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis: An Umbrella Review and Meta-Analyses of Randomised Controlled Trials in High-Income Contexts With Universal Healthcare Coverage.#345272NCBI PubMed Central
• Plasma 3,3’,5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3#129220PMC Full-Text (OAI)
• Tissue-specific transfer learning improves functional variant and therapeutic target discoveries in breast and prostate cancer#158306PLOS
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers#261495ClinicalTrials.gov
• A simple morphometric algorithm based on nuclear atypia features of invasive breast carcinoma: relationship with nuclear grade, Ki-67 level, and hormone receptor status#299166Springer Nature OA
• Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).#301701NCBI PubMed Central
• Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial#326119HAL (France)
• Co-encapsulated fluorescent magnetic nanoparticles for potential applications in breast cancer therapy: Exploratory in vitro and in vivo studies#11507HAL (France)
• Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial#274059HAL (France)
• Inhibition of Histone Demethylase LSD1 Suppresses CD47 Expression and Enhances Efficacy of CD47 Blockade in Breast Cancer#355132ODU Digital Commons
• Response to the letter Re: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting#218364IRIS
• Impact Of Blood Glucose Trajectories On Pathological Responses, Severity And Quality Of Life Associated With Cipn In Breast Cancer Women After Receiving Neo Adjuvant Chemotherapy: A Single Center Study In Pakistan#220244USM Repository
• A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer#295522OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment#299098Springer Nature OA
• Efficacité thérapeutique d’un anticorps humain anti-cathepsine D optimisé dans sa partie Fc en mono- et combothérapie dans les cancers du sein triple-négatifs#155998HAL (France)
• A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer.#269403NCBI PubMed Central
• Primary fibroblasts from BRCA1 mutation-carrying members of breast cancer families display a G1/S cell cycle checkpoint defect following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment.#315241Lancaster EPrints
• Trachystemon orientalis (L.) G. Don aqueous extract induces cell cycle arrest and apoptosis in MCF-7 breast cancer cells via multi-pathway modulation#211772Recep Tayyip Erdoğan University Institutional Repository
• Integrating enriched case data from national laboratory testing with population-based case-control analyses: a novel statistical likelihood-ratio methodology for PS4 applied to 325,345 breast cancer cases and 671,006 controls#272015bioRxiv / medRxiv
• <i>In silico</i> screening and molecular analyses identify apigenin from <i>Scutellaria barbata</i> as a potent AKT1 inhibitor in breast cancer#313074PLOS
• Impact of the COVID-19 pandemic on diagnosis, and healthcare utilization, among patients with cancer (lung, breast, and pancreas) and cardiovascular diseases (HF, AF, hypertensive, and chronic ischemic heart disease) in Germany: two systematic reviews.#220920NCBI PubMed Central
• Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Genetic Data#260366Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023#221850IRIS
• Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies#256861ClinicalTrials.gov
• Development of Genetic Testing Strategies for Hereditary Breast and Ovarian Cancer Risk Prediction by Analysis of Spectrum of Predisposing Mutations and Their Phenotypic Manifestations: Clinical Data#260360Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK‐2206 with an aromatase inhibitor#8198HAL (France)
• Acetone Fraction of the Red Marine Alga Laurencia papillosa Reduces the Expression of Bcl-2 Anti-apoptotic Marker and Flotillin-2 Lipid Raft Marker in MCF-7 Breast Cancer Cells.#238991HAL (France)
• Non-mutagenic Ru(II)–phosphine-based complexes induce mitochondria-mediated apoptosis in breast cancer cells: from 2D to 3D investigations#295842RI UFSCar
• Next Generation-Targeted Amplicon Sequencing (NG-TAS): An optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA#226052Apollo
• The effectiveness of the pregnancy adapted YEARS algorithm to safely identify patients for CT pulmonary angiogram in pregnant and puerperal patients suspected of having pulmonary embolism#345979University of Pretoria Repository
• Gene set analysis for time-to-event outcome: comparison of a new approach based on the generalized Berk–Jones statistic with existing methods in presence of intra gene-set correlation#253960HAL (France)
• Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.#179322HAL Science
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax#162462ClinicalTrials.gov
• Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights#257739HAL (France)